TXNRDs are homodimeric enzymes, and each monomer contains FAD- and NADPH-binding domains and a selenocysteine-containing catalytic site
Semaglutide injections are administered once weekly compared to daily liraglutide injections
Acknowledgements We would like to thank Jatinder Dhillon and the MedImmune Biologics Expression and Early Expression and Supply teams for generating the peptide-antibody fusions, Sarah Will and Arthur Suckow (MedImmune LLC, Gaithersburg, MD, USA), Dominic Corkill (MedImmune Ltd, Cambridge, UK), Michael Feigh (Gubra, Horsholm, Denmark), the MedImmune and AstraZeneca in vivo science teams for assistance in the design and conduct of rodent studies, Joerg Bluemel (MedImmune LLC, Gaithersburg, MD, USA) for supervising the non-human primate study as well as Nicholas Bhagroo (MedImmune LLC, Gaithersburg, MD, USA) for performing the in vitro glucose-stimulated insulin secretion assay
Losing even 5% of your body weight can meaningfully reduce your risk of conditions like heart disease and type 2 diabetes
The change in receptor profile, not the absolute dose potency, drives the result
Beyond cost considerations, clinical outcomes show promising results